Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q2 2020 Earnings Conference Call August 3, 2020 4:30 PM ET
Company Participants
Trevin Rard - IR
Mike Hunkapiller - CEO
Susan Barnes - CFO
Ben Gong - VP of Finance and Treasurer
Conference Call Participants
Doug Schenkel - Cowen
Kyle Mikson - Cantor Fitzgerald
Steven Mah - Piper Sandler
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Pacific Biosciences of California, Inc., Second Quarter 2020 Conference Call. At this all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to Trevin Rard. Thank you. Please go ahead, ma'am.
Trevin Rard
Thank you. Good afternoon, and welcome to the Pacific Biosciences second quarter 2020 conference call. We hope that you are keeping well during this time. Earlier today, we issued a press release outlining the financial results we will be discussing on today’s call, a copy of which is available on the Investors section of our website at www.pacb.com or, alternatively, as furnished on the Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.
With me today are Mike Hunkapiller, our Chief Executive Officer; Susan Barnes, our Chief Financial Officer; and Ben Gong, our Vice President of Finance and Treasurer.
Before we begin, I would like to remind you that on today’s call, we may be making forward-looking statements, including plans and expectations relating to our financial projections, research efforts, products and other future events, such as the impact of COVID-19 pandemic on our business, partners, customers and employees and the use of our products in COVID-19 research.
You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks and uncertainties and may differ
- Read more current PACB analysis and news
- View all earnings call transcripts